Independent minds. Global perspective. A publication for the builders
Biotechnology / New York City, NY

Adam Yaari.

Co-founder
Serinus Biosciences

Adam Yaari co-founded Serinus Biosciences, which develops AI-supported approaches to combination cancer therapies. His public biography describes entrepreneurship and biological research. The company applies systems-biology knowledge to investigate treatment resistance and identify combinations intended to address the ways cancer cells can escape a therapy.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

Adam Yaari and the story of Serinus Biosciences.

Serinus's founding account connects the venture to research on the causes of cancer and a focus on shared biological processes beneath different mutations. Its current description emphasizes explainable inference and combinations aimed at resistance mechanisms. The supplied material establishes that research thesis and development direction, rather than validated treatment performance. It does not independently demonstrate safety, clinical effectiveness, or the speed at which an investigational combination can reach patients.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    Serinus Biosciences — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗